#selpercatinib
Live, measured metrics for the hashtag #selpercatinib from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #selpercatinib
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mastodon.social (Mastodon public tags API) · fetched 2026-10-10 13:59 UTCNo measured public usage for #selpercatinib in the last 7 days. That is a real result, and a good one to know: this hashtag is wide open right now. We show a dash before we ever show a made-up number. Browse the trending index for tags with live measurements.
Related hashtags
measured · mastodon.social (Mastodon public search API) · fetched 2026-10-10 13:59 UTCNo related tags with measured usage found for #selpercatinib.
Live pulse
measured · Mastodon tag timeline · fetched 2026-10-10 13:59 UTCNo recent public posts found for #selpercatinib on Mastodon. Nothing measured, so nothing shown.
What “selpercatinib” means
WikipediaSelpercatinib, sold under the brand name Retevmo among others, is a targeted medication for the treatment of cancers in people whose tumors have an alteration in a specific gene. Before beginning treatment, the identification of a RET gene alteration must be determined using laboratory testing. Selpercatinib is taken by mouth.
“Selpercatinib” on Wikipedia (CC BY-SA) →#selpercatinib across platforms
every network with a public tag surfaceFollow #selpercatinib straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/selpercatinib